Access to anti-retroviral drugs, male in IDA blend
IDA blend: Access to anti-retroviral drugs, male was 74.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in IDA blend, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in IDA blend is 74.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 4.7% on the previous year and up 110.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in IDA blend peaked at 74.0% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in IDA blend, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.4% | +1079.1% |
| 2004 | 1.7% | +387.4% |
| 2005 | 3.6% | +108.5% |
| 2006 | 6.8% | +87.4% |
| 2007 | 9.5% | +40.1% |
| 2008 | 14.2% | +50.1% |
| 2009 | 18.9% | +33.3% |
| 2010 | 22.0% | +16.1% |
| 2011 | 24.1% | +9.5% |
| 2012 | 26.5% | +10.1% |
| 2013 | 31.8% | +20.2% |
| 2014 | 35.2% | +10.5% |
| 2015 | 40.4% | +14.7% |
| 2016 | 45.1% | +11.7% |
| 2017 | 50.7% | +12.5% |
| 2018 | 52.8% | +4.1% |
| 2019 | 56.9% | +7.7% |
| 2020 | 60.8% | +6.9% |
| 2021 | 64.5% | +6.0% |
| 2022 | 68.6% | +6.4% |
| 2023 | 70.7% | +3.1% |
| 2024 | 74.0% | +4.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.5% | 0.0% | 18.9% | 10 |
| 2010s | 38.5% | 22.0% | 56.9% | 10 |
| 2020s | 67.7% | 60.8% | 74.0% | 5 |
Countries ranked near IDA blend
- 11 Botswana 92.0% compare
- 12 Spain 91.0% compare
- 13 Burundi 90.0% compare
- 13 Malawi 90.0% compare
- 13 Namibia 90.0% compare
- 13 Switzerland 90.0% compare
- 17 France 89.0% compare
- 17 Iceland 89.0% compare
- 17 Ireland 89.0% compare
- 17 Netherlands 89.0% compare
- 17 Romania 89.0% compare
- 17 Zimbabwe 89.0% compare
More gender data for IDA blend
- Labor force, female 110.95 million (2025)
- Labor force, female, per capita 0.1609 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.73 % change on previous year (2025)
- Labor force, female, per square kilometre 21.38 units per square kilometre (2023)
- Ratio of female to male youth unemployment rate (% ages 15-24) 130.6% (2025)
- School life expectancy, primary to tertiary, female 8.56 years (2019)
- School life expectancy, primary to tertiary, male 9.46 years (2019)
- Proportion of women in ministerial level positions 16.4% (2025)
- Literacy rate, adult female 61.5% (2024)
Frequently asked questions
- What is access to anti-retroviral drugs, male in IDA blend?
- Access to anti-retroviral drugs, male in IDA blend was 74.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in IDA blend?
- The highest recorded value was 74.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in IDA blend?
- The lowest recorded value was 0.0% in 2000.
- How does IDA blend rank for access to anti-retroviral drugs, male?
- IDA blend ranks 14th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in IDA blend?
- Over the last ten years it is up 110.3%. The long-run trend across the full record is volatile.
- Where does this IDA blend data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.